# Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

> **NCT00407069** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 286 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00407069
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2016-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407069, "Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00407069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*